$JNJ

$266.35 +$2.54 (0.96%) Live

$JNJ Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$JNJ Management Team

Mr. Joseph Wolk

Chief Financial Officer

Executive Vice President

Age 58

Compensation $12.62M USD

Sex Male

Ms. Kathryn Wengel

Executive Vice President

Chief Technology Officer and Risk Officer

Age 59

Compensation -

Sex Female

Mr. James Swanson

Executive Vice President

Chief Information Officer

Age 59

Compensation -

Sex Male

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

Age 56

Compensation -

Sex Female

Ms. Elizabeth Forminard

Executive Vice President

Chief Legal Officer

Age 54

Compensation -

Sex Female

Mr. Tim Schmid

Executive Vice President

Worldwide Chairman of MedTech

Age 55

Compensation $11.86M USD

Sex Male

Ms. Jennifer Taubert

Executive Vice President

Worldwide Chairman

Innovative Medicine

Age 61

Compensation $11.19M USD

Sex Female

Mr. Joaquin Duato

Chairman of the Board

Chief Executive Officer

Age 62

Compensation $24.30M USD

Sex Male

Prof. Dr. John Reed

Executive Vice President - Innovative Medicine

Research and Development

Age 67

Compensation $9.304M USD

Sex Male

Ms. Jessica Moore

Vice President - Investor Relations

Age -

Compensation -

Sex Female

Ms. Kristen Mulholland

Chief Human Resources Officer

Executive Vice President

Age 58

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Joseph Wolk Chief Financial Officer Executive Vice President	58	$12.62M USD	Male
Ms. Kathryn Wengel Executive Vice President Chief Technology Officer and Risk Officer	59	-	Female
Mr. James Swanson Executive Vice President Chief Information Officer	59	-	Male
Ms. Vanessa Broadhurst Executive Vice President - Global Corporate Affairs	56	-	Female
Ms. Elizabeth Forminard Executive Vice President Chief Legal Officer	54	-	Female
Mr. Tim Schmid Executive Vice President Worldwide Chairman of MedTech	55	$11.86M USD	Male
Ms. Jennifer Taubert Executive Vice President Worldwide Chairman Innovative Medicine	61	$11.19M USD	Female
Mr. Joaquin Duato Chairman of the Board Chief Executive Officer	62	$24.30M USD	Male
Prof. Dr. John Reed Executive Vice President - Innovative Medicine Research and Development	67	$9.304M USD	Male
Ms. Jessica Moore Vice President - Investor Relations	-	-	Female
Ms. Kristen Mulholland Chief Human Resources Officer Executive Vice President	58	-	Female

Board of Directors

From the proxy statement filed Mar 11, 2026

Directors

serving now

Independent

11 of 12

stated in the proxy

Average tenure

5.9 years

from year joined

CEO also chairs the board

Yes

Joaquin Duato

Director	Age	On board	Independent	Committees	Other public boards	Pay
Mary C. Beckerle	71	2015 11 years	Independent	Science & Technology · Chair Regulatory Compliance & Sustainability	Exelixis	Not stated
Jennifer A. Doudna	62	2018 8 years	Independent	Nominating & Corporate Governance Science & Technology	Tempus AI, Inc.	Not stated
Joaquin Duato Board chair, CEO	63	2022 4 years	Not independent	Finance · Chair	None stated	Paid as CEO
Marillyn A. Hewson Lead independent director	72	2019 7 years	Independent	Nominating & Corporate Governance · Chair Compensation & Benefits Finance	Chevron Corporation	Not stated
Paula A. Johnson	66	2023 3 years	Independent	Nominating & Corporate Governance Science & Technology	None stated	Not stated
Hubert Joly	66	2019 7 years	Independent	Audit · Chair Nominating & Corporate Governance Special Committee - Orthopaedics Separation	S&P Global, Inc.	Not stated
Mark B. McClellan	62	2013 13 years	Independent	Regulatory Compliance & Sustainability Science & Technology	Alignment Healthcare, Cigna Corporation	Not stated
John G. Morikis	62	2025 1 year	Independent	Audit Compensation & Benefits	General Mills, Inc., United Parcel Service, Inc., Whirlpool Corporation	Not stated
Daniel E. Pinto	63	2025 1 year	Independent	Audit Compensation & Benefits Special Committee - Orthopaedics Separation	None stated	Not stated
Mark A. Weinberger	64	2019 7 years	Independent	Regulatory Compliance & Sustainability · Chair Audit Special Committee - Orthopaedics Separation	JPMorganChase, MetLife Inc., Saudi Aramco	Not stated
Nadja Y. West	64	2020 6 years	Independent	Regulatory Compliance & Sustainability Science & Technology Special Committee - Orthopaedics Separation	Nucor Corporation, Tempus AI, Inc., Tenet Healthcare Corporation	Not stated
Eugene A. Woods	61	2023 3 years	Independent	Compensation & Benefits · Chair Regulatory Compliance & Sustainability	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Mar 11, 2026

Sister of Mr. Joseph Wolk

sister of Mr. Joseph Wolk, Executive Vice President, Chief Financial Officer

$245,969

2025

Employment as Talent Mobilization Leader at a wholly-owned subsidiary of the Company, with total 2025 compensation of $245,969.

With Johnson & Johnson Services, Inc. Open in proxy

Brother-in-law of Ms. Kathryn Wengel

brother-in-law of Ms. Kathryn Wengel, Executive Vice President, Chief Technical Operations & Risk Officer

Approximately $13.93 million

2025

Company engaged law firm where the brother-in-law is a partner for legal services; Company paid approximately $13.93 million in 2025.

With Nelson Mullins Riley & Scarborough LLP Open in proxy

Comments

Company Executives

$JNJ Management Team

Mr. Joseph Wolk

Ms. Kathryn Wengel

Mr. James Swanson

Ms. Vanessa Broadhurst

Ms. Elizabeth Forminard

Mr. Tim Schmid

Ms. Jennifer Taubert

Mr. Joaquin Duato

Prof. Dr. John Reed

Ms. Jessica Moore

Ms. Kristen Mulholland

Board of Directors

Related-party transactions